It is generally accepted that T cells produce lymphokines during the generation and expression of ceil-mediated immunity (reviewed in 1). Lymphokine preparations often exhibit antiviral activity that is known to be mediated by interferon (IFN)) This IFN, because of its distinct antigenic and physicoehemical properties, has been designated IFNy to differentiate it from the IFNa and IFNfl classes (2) . In addition to its distinct molecular nature, IFNy has been reported to be relatively more active than other classes of IFN in its ability to directly inhibit the growth of neoplastic cells (3, 4) as well as in its ability to function as an immunomodulator (5, 6) . Because of its T cell origin and pronounced actions on immune responses, it is conceivable that the primary role of the lymphokine IFNy might be one other than its antiviral action.
IFNy has been detected in sera of immunized mice after injection of sensitizing antigen (7) or in vitro after exposure of lymphoid cells of immune animals to antigen (8, 9) . In place of specific antigenic stimulation, polyclonal T cell mitogens such as phytohemagglutinin (PHA) or eoneanavalin A (Con A) have been used in vitro to induce the synthesis of low levels of IFNy from lymphoid cells of nonimmune animals (10, 1 1). Because polyclonal mitogens stimulate a far greater number of T cells than does specific antigen, it was considered of interest to determine whether lymphocytes from animals actively expressing T cell-mediated immunity might produce higher IFNy levels in response to PHA or Con A. The studies presented in this paper show that spleen cells from animals given an immunizing infection with the bacterium Listeria monocytogenes consistently produced 10-to 20-fold more IFNy than cells from normal mice after exposure to PHA or Con A. This finding has enabled the development of a reproducible method for the production of high-titered murine IFNy (MulFNy). These studies also reveal a striking parallel between the development ofT cell-mediated anti-Listeria immunity (12, 13) and an enhanced ability of spleen cells from the responding mice to produce IFNy in response to PHA or Con A stimulation. Some physicochemical properties of mitogen-induced MuIFNy are also presented.
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Identification of MuarFNT-producing Cells. The MulFNT-producing cells were tested for their susceptibility to C-mediated lysis after treatment with monoclonal antibodies directed against Thy-l.2, Lyt-l.2, Lyt-2.2, and I-A k. The monoclonal anti-Thy-l.2 was originally produced by Marshak-Rothstein et al. (19) and obtained from the Salk Institute, La Jolla, CA. The anti-Lyt-1.2 and anti-Lyt-2.2 was purchased from New England Nuclear, Boston, MA. Anti-I-A k antibody was produced from a hybridoma derived by Oi et al. (20) and obtained from the Salk Institute. Rabbit serum C was prescreened on thymocytes to determine lytic activity and was found at all dilutions tested to give <10% spontaneous lysis. Hybridomas secreting antiThy-l.2 antibody or anti-I-A k were propagated in RPMI 1640 supplemented with 10% FBS. Supernatants from these cultures were used as a source of antibody at a 1:10 dilution. The antiLyt antibodies were used at a two-to fivefold excess of that required for lysis of the specific cell type in the preparation.
Spleen cells from animals immunized 6 d earlier with L. monoqytogenes were suspended at 5 × 106 ceUs/ml in t.0 ml of RPMI 1640 containing 1% FBS and 10 #g/ml gentamycin. The desired concentration of antibody was added to the appropriate tubes and the suspension incubated in a 37°C water bath. 10 min later, C was added to a final dilution of 1:10. After a 1-h incubation, cells were washed free of antibody, and cell death was quantitated by exclusion of ethidium bromide (21) .
For the C-mediated cytolytic studies, a modification of the procedure outlined above for induction of MuIFN 7 synthesis was used. The antibody-treated cells were distributed in 0.2-ml quantities to wells of a 96-well microtiter plate (Costar, Data Packaging). PHA was added to a final concentration of 5 #g/ml to each experimental group consisting of triplicate wells. After 24 h incubation, the supernatants from each well of the respective experimental group were pooled and assayed for IFN activity.
Chemicals and Reagents. Purified Con A (type IV) was purchased from Sigma Chemical Co., and purified PHA was obtained from Burroughs Wellcome, Research Triangle Park, NC. Staphylococcal enterotoxin A was produced by the Microbiology Biochemistry Branch, Division of Microbiology, Food and Drug Administration, Cincinnati, OH. Stock solutions (1 mg/ml) of the mitogens were prepared in sterile distilled H20.
Cultures of L cells (strain Lpa) and pure bone marrow-derived macrophages were induced with either Newcastle disease virus (NDV) or polyinosinic-polycytidylic acid (poly [I] . poly [C]) according to published procedures (22) (23) (24) to provide preparations of MuIFNa and MuIFNfl for use in these studies.
IFN and Antiserum Neutralization Assays. IFN assays were carried out as previously reported (25) using the L929B strain of L cells and vesicular stomatitis virus as the challenge virus. Because no MuIFNy standard is available, included in each assay was the MuIFN international standard (G-002-904-511), and all titers were corrected against this international standard.
The antiserum neutralization assays of antiviral activities were done as described by Havell et al. (26) also using L929B cells and vesicular stomatitis virus. The anti-L cell MuIFN serum used was the kind gift of Dr. Erwin Braude and Dr. W. E. Stewart II (Memorial SloanKettering Cancer Center, NY). This antiserum, which neutralizes both MuIFNa and MuIFN/~, was raised in a goat by immunization with NDV-induced L cell IFN (specific activity, 106 U/mg) known to possess both MuIFNa and MuIFN/~ activity (27, 28) . The rabbit antiMuIFN 7 neutralizing serum was the kind gift of Dr. Juana Wietzerbin (Curie Institute, Paris, France). This antiserum was raised according to published procedures (29) .
Molecular Weight and Isoelectric Point Determinations. Molecular weight determinations were carried out by means of gel filtration column chromatography using Bio-Gel P-60, 100-200 mesh (Bio-Rad Laboratories, Richmond, CA) as the column matrix. The column buffer was 0.05 M Na citrate with 1 M NaCI, pH 6.0. The column (73 × 2.5 cm) was run at 4°C and calibrated with the following molecular weight markers: rabbit IgG, 150,000; ovalbumin, 43,000; myoglob[n, 18,500; and cytochrome C, 12,000.1-ml fractions were collected at a column flow rate of 15 ml/h.
Chromatofocusing, a technique originally described by Sluyterman et al. (30, 31) , was used to determine the isoelectric points of the IFN in various preparations. A chromatofocusing kit containing the ion exchanger PBE 94 as well as the polybuffer exchangers, polybuffers 96 and polybuffer 74, were purchased from Pharmacia Fine Chemicals, Div. of Pharmacia, Inc. Samples and the ion exchanger PBE 94 were equilibrated in starting buffer (0.025 M Trisacetate, pH 8.4), and the column was packed (14 × 0.5 cm) with PBE 94. The sample to be chromatofocused was then run into the column bed, and the generation ofa pH gradient (5.0-8.0) was achieved by elution with the polybuffer system (3% polybuffer 96 and 7% polybuffer 74, adjusted to pH 5.0 with acetic acid). The column was run at room temperature with a flow rate of 15 ml/h. 1-ml fractions were collected and assayed for IFN activity, and the pH of each sample measured at room temperature.
Results
Enhanced IFN Production by Spleen Cells from Listeria-immune Mice. Because T cell mitogens are inducers of IFNy in nonimmune animals (10, 11) , it was considered of interest to determine the relative ability of spleen cells obtained from mice actively expressing T cell-mediated antibacterial immunity to produce IFN in response to polyclonal T cell activators. Spleen cells from both control and mice infected intravenously 6 d earlier with Listeria were incubated for 24 h with the designated concentrations of the mitogenic agents ( Table I ). The results of these studies show that spleen cells from Listeria-immune animals produced levels of IFN at least 16-fold higher than similarly treated cultures from nonimmune mice. It was repeatedly observed in 20 separate experiments that spleen cell cultures from Listeria-immune mice produced 10-20 times more antiviral activity than normal cells induced with Con A or PHA, although the absolute IFN units fluctuated two-to fourfold between experiments. Specific antigenic stimulation of spleen cells from Listeria-immune mice with a preparation of soluble Listeria antigen(s) resulted in the synthesis of low levels of IFN, but the antigen failed to elicit IFN in nonimmune spleen cell cultures. Marginal levels of IFN activity (<---2) were detected in supernatants from Listeriaimmune spleen cell cultures not incubated with the mitogens.
Characterization of Immune Spleen Cell IFN. The y class of interferons is characterized as being inactivated at low pH (2.0) and by the failure of antisera raised against IFNa and IFN~ to neutralize its antiviral activity (32, 33) . In the following studies, with the * 2-ml cultures of spleen cells (107 cells/ml) were incubated for 24 h designated final concentrations of mitogenie agents.
TA~L~ I MuIFNy Production after Mitogenic or Antigenic Stimulation of Spleen Cells from Normal or Listeria-immune Mice
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the IFN produced by Listeria-immune spleen cell cultures stimulated with Con A or PHA were analyzed as to their stabilities at pH 2.0 and to their antigenic properties. Murine IFN preparations containing both MuIFNa and MuIFNfl were included as controls in these experiments. These MuIFN were produced by L cells and by pure cultures of macrophages induced with NDV or poly (I). poly (C) (22) (23) (24) . All samples were dialyzed at 4°C against a pH 2.0 buffer for 5 d and returned to pH 7.4 by dialysis against PBS. The results in Table II show that acidification of the L cell and macrophage IFN preparations resulted in no more than a twofold decrease in antiviral activities, whereas the mitogen-induced spleen cell IFN were found to be relatively more acid labile. In repeated pH 2.0 lability studies, it was observed that each MuIFN), preparation produced in vitro possesses a fraction (3-15% of the original activity) that was not inactivated by the 5-d acid treatment.
The antigenic classification of the IFN preparations used in the pH stability studies was done through the use of specific anti-MuIFN sera. A goat anti-MuIFN serum possessing both anti-MuIFNa and anti-MuIFNfl activity and a rabbit anti-MuIFNy serum were used to determine the degrees to which the antiviral activities of each test IFN could be neutralized (Table II) . The antiserum possessing specific populations of antibodies directed against MuIFNa and MuIFNfl exhibited very high neutralizing titers for the macrophage and L cell IFN but failed to inhibit the antiviral activities of either the PHA or Con A-induced spleen IFN preparations. Conversely, the rabbit anti-MuIFN't serum neutralized only the mitogen-induced spleen cell IFN. Similar neutralization studies performed with the acid-stable portion of the PHA-indueed spleen cell IFN showed that it also was IFNy by its antigenic properties (data not shown). Thus, based on the relative acid lability and the serological results, the major IFN activity produced by the spleen cell cultures was MuIFNy. However, it should be mentioned that, whereas the major antiviral activity in these preparations is MuIFNT, we cannot exclusively eliminate the possible presence of low levels of other antigenic classes of MulFN. In the antibody neutralization studies, a final concentration of 10 U/ml of antiviral activity is reacted, and if<10% of the activity (<1 unit) is mediated by an IFN molecule not neutralized by the antibody, its antiviral activity would not be detected in this neutralization assay (34) .
Temporal Relationship between the Development of Anti-Listeria Immunity and Enhanced Capacity of Spleen Cells to Produce MuIFNy.
The following experiments were designed to determine whether the enhanced production of MuIFNy by spleen cells from Listeria-immune mice coincided with the peak of the antibacterial-immune response.
This was tested by measuring the capacity of spleen cells harvested against time of
Listeria infection'to produce PHA-induced MuIFNy and to passively transfer antibacterial immunity to normal recipients. The results illustrated in Fig. 1 clearly demonstrate a parallel between the development of antibacterial immunity and the ability of spleen cells to produce high-titered MuIFNy. Thus, the ability of spleen cells to produce MuIFNy and to transfer protective immunity developed, peaked, and declined at the same times.
Cellular Origin of MuIFNy. Evidence indicates that T cells are the major producers of lymphokines, although B cells have also been implicated as potential contributors of these soluble mediators (35, 36) . In the following studies, monoclonal antibodies and C were used to determine the nature of the spleen cells producing MuIFNy. The findings presented in Table III reveal that treatment of cells with anti-Thy-l.2 plus C virtually abolished production of MuIFNy. It should be noted that the low level of IFN activity that was produced after anti-Thy-1.2 plus C treatment was identified as MuIFNy by its lability at pH 2.0 and by its antigenic properties (results not shown). The synthesis of this residual MuIFNy could conceivably by attributed to small numbers ofT cells possessing little or no Thy-1 antigen (37) . in contrast to the almost total elimination of MuIFNy production by anti-Thy-l.2, destruction of B lympho- #g/ml gentamycin. Antibody plus C was added to the appropriate groups as described in Materials and Methods. After antibody treatment, all groups were induced with PHA (5 p,g/ml). After antibody plus C treatment, viable cells were determined by exlusion of ethidium bromide, and the number of viable cells was then adjusted to 5 X 10 s cells/ml before the addition of PHA.
cytes with anti-IgG plus C or anti-I-A plus C had no detectable effect on the titer of PHA-induced MuIFNy.
Similar studies were performed to identify the T cell subpopulation(s) producing
MuIFNy through the use of specific cytolytic monoclonal antibodies directed against Lyt differentiation antigens. In Table IV , it is shown that the T cells producing MuIFNy were more susceptible to destruction by anti-Lyt-1.2 plus C than with anti-Lyt-2.2 and C. The combined effects of the two anti-Lyt antibodies reduced by MuIFNy titer to slightly below that of the anti-Thy-l.2 plus C-treated cells. Reduced MuIFN 7 titers were also observed when cells treated with anti-Lyt-l.2 plus C were restored to the original number per culture (5 × 10 e cells/ml). Based on this observation, it is reasonable to conclude that the T cell subpopulations not destroyed by anti-Lyt-l.2 plus C are not the contributors of the major portion of the MuIFNy activity. This finding does not rule out the possibility that for maximum MuIFNy production, Lyt-l+2 -cells might have to interact with other cell population(s). This is based on the additional findings presented in Table IV , which show that almost maximum MuIFN 7 titers were obtained by (a) restoring the cells remaining after anti-Lyt-2.2 plus C treatment to the original number of cells per culture (5 X 106 cells/ml) or (b) by combining cells surviving after treatment with anti-Lyt-l.2 with those surviving after treatment with anti-Lyt-2.2 plus C. However, the increase in titers in each of the above cases might be on the borderline of significance because the MuIFN 7 titer after anti-Lyt-2.2 plus C treatment was only threefold (384) lower than C-treated controls (1,024). Thus, this difference falls close to the inherent twofold error of the interferon assay. Supernatants of duplicate cultures from each mitogen-treated group were collected at the times indicated, pooled, and centrifuged. The supernatants were stored at 4°C until they were assayed for antiviral activity. A, Con A; C), PHA.
Kinetics of MuIFNy
supernants as early as 4 h after the addition of the mitogens, with peak levels occurring at 18 h. After this time, MuIFNy levels remained constant for an additional 48 h. From the slopes of the production curves and the levels of IFN released, it is concluded that the rate of synthesis and quantities of MuIFNy produced by cultures of Listeriaimmune spleen cells was the same when PHA or Con A were used as inducers. The kinetics of MuIFNy release are similar to those reported for alloantigen-induced MuIFN~, (38) .
MuIFNy Induction by Different Concentrations of T Cell Mitogens.
A series of studies was carried out to establish the optimum concentrations of T cell mitogens required to induce the maximum synthesis of MuIFNy in spleen cell cultures from Listeriaimmune and control mice. In addition to Con A and PHA, staphylococcal enterotoxin A (SEA)was included in these studies because it has been reported to be a potent inducer of IFNy in both murine and human cell systems (11, 39) . The findings presented in Table V reveal that the MuIFNy levels from the Listeria-immune spleen ceils were at least 10-fold greater than the corresponding yields from similarly treated nonimmune control cells. MuIFNy production plateaued in immune spleen cell cultures incubated with PHA concentrations in the range of 0.5-10 #g/ml, whereas Con A elicited the highest titers of MuIFNy activity in both control and immune cultures at a concentration of 1 /.tg/ml. The SEA failed to induce MuIFNy in nonimmune control cultures with any of the concentrations tested. In fact, SEA was only effective in inducing MuIFNy in immune spleen cell cultures, with the highest level of antiviral activity being detected in cultures incubated with the highest concentration (I0 #g/ml) of SEA tested.
The diterpene ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and the structurally related compound-mezerein have been reported (40) to enhance the levels of human IFNy (HuIFNy) produced by primary cultures of human leukocytes stimulated by PHA or several other T cell mitogens. Therefore, experiments were performed to determine whether these esters might also further augment the yield of MuIFNy produced by Listeria-immune spleen cells. In these studies, cultures of spleen cells from immune mice were incubated with different concentrations of TPA or mezerein 3 h before the addition of PHA (5 #g/ml). Little or no enhancement in interferon yields , was applied to the chromatofocusing column. Conditions of elution and generation of the pH gradient are as presented in Materials and Methods. 1-ml fractions were assayed for antiviral activity, and the pH of each fraction was determined at room temperature. The MulFNy unitage applied was 1,536 units, and the total units recovered was 484.
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was observed in the cultures pretreated with either agent in the concentration ranges (1-50 T/g/ml) reported by others to enhance HuIFN7 levels (results not shown).
Molecular Weight of MuIFNy. The availability ofhigh-titered MuIFN7 preparations produced by PHA-induced Listeria-immune spleen cells has enabled the analysis of certain of its physicochemical properties. Molecular weight determinations were made by gel filtration chromatography using Bio-Gel P-60 under nondenaturing conditions. It would have been preferable to estimate the molecular weight of MuIFNy by sodium dodeeyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), however, treatment of MuIFNT with SDS (0.1 or 1%) under both reducing and nonreducing conditions performed at a number of temperatures consistently resulted in substantial losses of antiviral activity. Treatment of HuIFNT with this anionic detergent has also been reported to cause a ~90% loss in HuIFNT antiviral activity (41) . The elution profile of MuIFNT from the Bio-Gel P-60 column is presented in Fig. 3 . The MuIFNT activity has an estimated 38,000 + 4,000 tool wt, and the recovery of antiviral activity was in the order of 50% of the applied unitage.
Isoelectric Point of MuIFNy. The isoelectric point of MuIFNy was determined by chromatofocusing (30, 31) . Preliminary isoelectric focusing studies using ampholytes to generate a pH gradient in acrylamide gels revealed that, unlike MulFNa and MuIFN/~ (42), the MuIFN T focused in the acidic region of the gradient. Therefore, the polybuffer system used to develop a pH gradient during chromatofocusing was adjusted to generate a linear pH gradient between pH 5.0-8.0. The resulting elution profile of MuIFNT activity from the chromatofocusing column is presented in Fig. 4 . Greater than 90% of the recovered MuIFN T focused between pH 5.0-7.0, and the MulFN T is shown to exhibit considerable molecular charge heterogeneity. A major peak of MuIFN T activity focused between pH 5.0-5.6, with a second extremely disperse region of activity from pH 5.8-7.0.
Discussion
The studies presented in this paper show that T lymphocytes from the spleens of animals with an ongoing T cell-mediated immune response to Listeria infection acquire the ability to produce significantly more MuIFN T than splenic T cells from uninfected mice. In addition, it was revealed that the ability of spleen cells from immune mice to produce high-titered MuIFNT developed and declined eoncordantly with the production and loss of T cells capable of passively transferring anti-Listeria immunity. Prior studies have shown that a number of other parameters of cellular activity associated with an onging cell-mediated anti-Listeria response display similar kinetics of generation and decay. These include spleen cell proliferation, spleen cellularity, delayed sensitivity to Listeria antigens (17) , and macrophage activation (43) . Our results indicate that during the generation of anti-Listeria immunity, there is an enlargement of a T cell subpopulation capable of producing MuIFN 7. An alternative explanation is that the T cells in the normal spleen that are capable of producing low titers of MuIFNy are individually activated to produce more IFN as a result of infection. Although we have only quantitated the enhancement of MuIFN T synthesis by spleen cells stimulated with T cell mitogens during the generation of antibacterial immunity, it would be of interest to determine whether the production of other mitogen-induced lymphokines is also enhanced.
The T cell origin of MuIFNT was established by showing that treatment with antiThy-l.2 plus C greatly dimishishes the production of this lymphokine. In contrast, treatment of cells with anti-I-A or anti-IgG to destroy B cells did not inhibit MuIFNy synthesis. The MuIFNy-secreting T cells were relatively susceptible to C-mediated lysis with anti-Lyt-l.2, which reduced the MuIFNT titer to nearly the same level as treatment with anti-Thy-l.2. This is not surprising because published studies have shown that virtually all T cells outside the thymus display Lyt-1 antigens on their surface, though not all are susceptible to C-mediated lysis (37) . Treatment of spleen cells with anti-Lyt-2.2 + C, on the other hand, only slightly reduced the titer of MulFNy. If the MulFNy-secreting lymphocytes displayed Lyt-1+2 +, then they should be equally susceptible to destruction by either anti-Lyt-1 or anti-Lyt-2. Therefore, there can be little doubt that the Lyt-l+2 -T lymphocyte is the main producer of MuIFNy in this system. A small contribution by Lyt-1-2 + T cells must be considered, however, even though the reduced production caused by anti-Lyt-1-2 + antibody is close to the limitations of the inherent twofold error of the IFN assay. These findings are in contrast to an earlier publication (44) that reported that an Lyt-1-2 + T cell was the major source of MuIFNy in animals immunized with Calmette-Guerin bacillus and challenged with specific antigen. These authors also reported the MuIFNyproducing cell was destroyed by anti-Ia and anti-IgG. It might be significant that T cells within the Lyt-l+2 -population are known to secrete interleukin 2 and that interleukin 2 is generated without participation of other T cells (45) .
The criterion most widely used to differentiate IFNT from other IFN is its loss of antiviral activity after acidification. It has been repeatedly observed that MuIFNy is relatively more labile at pH 2.0 than other MuIFN. However, we have always detected a variable fraction (3-15% of the total pre-acidified unitage) within MuIFNy preparations that remains active after 5 d pH 2.0 treatment. Similar findings were reported by Wietzerbin et al. (46) . A potent rabbit antiserum raised against a partially purified MuIFNy (5 Z 10 ~ U/mg protein) neutralized the acid-stable MuIFNy component, whereas a neutralizing antiserum possessing specificity for both MuIFNa and MuIFNfl did not neutralize this activity. Thus, based on this serological analysis, it is possible that not all MuIFNy molecules are acid labile. The heterogeneity of the MuIFNT molecules in the PHA-induced preparations is evidenced by additional findings in this paper. For example, isoelectric point determinations by means of chromatofocusing revealed that the MuIFNy molecules are primarily acidic proteins focusing in a broad pH range from 5.0-7.0. Addtional studies (E. A. Havell and G. L. Spitalny, manuscript submitted for publication) have shown that MuIFNy antiviral activity focusing between pH 5.0 and 5.6 binds specifically to a Con A affinity column, which indicates its glycoprotein nature. Molecular weight determinations by means of gel filtration chromatography on Bio-gel P-60 revealed the molecular weight of MuIFNT to be 38,000 __. 4,000. Studies by others have established the molecular weight of other murine lymphokines to be within a similar size range (47, 48) . However, because our molecular weight studies were carried out under nondenaturing conditions, we cannot rule out the possibility of complexes of low molecular weight MuIFNT yielding an apparent 38,000 mol wt under the conditions used for the molecular weight estimations. With regard to this last point, Yip et al. (48) originally reported that the molecular weight of HuIFNT estimated by gel filtration chromatography to be 58,000, but later found (41) that the remaining activity after SDS treatment could be resolved by SDS-PAGE into 25,000-and 20,000-mol wt components. This suggests the molecular aggregates cause the apparent higher molecular weight forms observed under nondenaturing conditions. The molecular diversity of MuIFNT could conceivably result from a variety of factors that have been shown to be responsible for the molecular heterogeneity within other IFN preparations. These include (a) distinct IFN gene classes and their differential induction in different cell types (50, 51) , (b) multigene IFN families within antigenically distinct IFN classes (52) , and (c) microheterogeneity caused by differing degrees of post-translational processing, such as in the glycosylation of IFN proteins (53, 54) .
The exact role, if any, played by MuIFNy in the regulation of immunity is still a matter of conjecture. Although there is no direct evidence for a function of MuIFNy in anti-Listeria immunity, the parallel development of T cells that exhibit enhanced production of MuIFNy and ofT cells that mediate immunity is perhaps suggestive of an important role for MuIFNy in cell-mediated immunity in general. The elucidation of the possible functional role(s) of MuIFNy in immunity will be made more difficult in view of the fact that distinct molecular populations of MuIFNy are produced by T cells. Summary Spleen cell cultures derived from animals infected 6 d earlier with Listeria monocytogenes produced 10-20-fold more murine interferon y (MuIFNy) than spleen cells from nonimmune mice in response to stimulation with T cell mitogens. A striking temporal association was found between the enhanced synthesis of MuIFNy and the development of anti-Listeria immunity in that both the potential for increased MuIFNy production and the generation of Listeria-protective T cells developed and then decayed in unison. Treatment of spleen cells with monoclonal anti-Thy-l.2 plus complement virtually abolished the ability of cells from Listeria-immune mice to synthesize MuIFNy. The T cells producing MuIFNy were found to be more susceptible to complement-mediated lysis with monoclonal anti-Lyt-l.2 than with monoclonal anti-Lyt-2.2. The production of MuIFNy was not affected by treating spleen cells with anti-IgG antisera or with a monoclonal antibody directed against I-A specificities. MulFN,/was detected 4 h after the beginning of mitogenic stimulation of spleen cell cultures, and peak levels of MuIFNT were reached by 18 h. The IFN synthesized by mitogen-induced spleen cells derived from Listeria-immune mice were relatively labile at pH 2.0 and neutralized by a rabbit anti-MuIFNy serum but not by an antiserum having specificities for MuIFNa and MuIFNfl. The apparent molecular weight of the MuIFNy, as estimated by molecular sieving on a Bio-gel P-60 column, was estimated to be 38,000, and the isoelectric point as determined by chromatofocusing was extremely heterogeneous, ranging between pH 5.0 and pH 7.0.
